Evernest Financial Advisors’s Sanara MedTech SMTI Stock Holding History

Evernest Financial Advisors’s Portfolio SMTI Stock Details SMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$606K	Buy	+25,700	New	+$531K	0.13%	108

Other funds holding SMTI

SWM

Stonebridge Wealth Management Oak Brook, Illinois $112M AUM 23.07% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return

SIC

Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

EWA

EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.72% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Evernest Financial Advisors's SMTI Position: Q2 2026 in Review

Evernest Financial Advisors opened a new position in Sanara MedTech (SMTI) in Q2 2026: 25,700 shares worth $606K. The stake represents 0.13% of the portfolio and ranks #108 among its holdings.

20 funds tracked by Wall St. Rank hold SMTI as of Q2 2026.

Evernest Financial Advisors held 25,700 shares of Sanara MedTech worth $606K as of Q2 2026.
Sanara MedTech was a new Evernest Financial Advisors position in Q2 2026.
Sanara MedTech made up 0.13% of Evernest Financial Advisors's portfolio in Q2 2026, its #108 holding.
20 funds tracked by Wall St. Rank held Sanara MedTech as of Q2 2026.

Based on Evernest Financial Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.